The University of Liège wishes to use cookies or trackers to store and access your personal data, to perform audience measurement. Some cookies are necessary for the website to function. Cookie policy.
  | LOUIS, T., Lucia, F., Cousin, F., MIEVIS, C., Jansen, N., Duysinx, B., Le Pennec, R., Visvikis, D., Nebbache, M., Rehn, M., Hamya, M., Geier, M., Salaun, P.-Y., Schick, U., Hatt, M., Coucke, P., Lovinfosse, P., & Hustinx, R. (19 April 2024). Identification of CT radiomic features robust to acquisition and segmentation variations for improved prediction of radiotherapy-treated lung cancer patient recurrence. Scientific Reports, 14 (1), 9028. doi:10.1038/s41598-024-58551-4  Peer Reviewed verified by ORBi |
 | Lucia, F., MIEVIS, C., Jansen, N., Duysinx, B., Cousin, F., LOUIS, T., BAIWIR, M., ERNST, C., WONNER, M., Hustinx, R., Lovinfosse, P.* , & Coucke, P.*. (2024). Predictive clinical and dosimetric parameters for risk of relapse in early-stage non-small cell lung cancer treated by SBRT: A large single institution experience. Clinical and Translational Radiation Oncology, 100720. doi:10.1016/j.ctro.2023.100720 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Lucia, F., LOUIS, T., Cousin, F., Bourbonne, V., Visvikis, D., MIEVIS, C., Jansen, N., Duysinx, B., Le Pennec, R., Nebbache, M., Rehn, M., Hamya, M., Geier, M., Salaun, P.-Y., Schick, U., Hatt, M., Coucke, P., Hustinx, R., & Lovinfosse, P. (2024). Multicentric development and evaluation of [ 18 F]FDG PET/CT and CT radiomic models to predict regional and/or distant recurrence in early-stage non-small cell lung cancer treated by stereotactic body radiation therapy. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-023-06510-y Peer Reviewed verified by ORBi |
 | Cousin, F., Louis, T., Dheur, S., Aboubakar, F., Ghaye, B., Occhipinti, M., Vos, W., Bottari, F., PAULUS, A., Sibille, A., VAILLANT, F., Duysinx, B., Guiot, J., & Hustinx, R. (25 March 2023). Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Cancers, 15 (7), 1968. doi:10.3390/cancers15071968 Peer Reviewed verified by ORBi |
 | Gommes, C., Louis, T., Bourgot, I., Blacher, S., Noël, A., & Maquoi, E. (2023). Remodelling of the fibre-aggregate structure of collagen gels by cancer-associated fibroblasts: a time-resolved grey-tone image analysis based on stochastic modelling. Frontiers in Immunology, 13. doi:10.3389/fimmu.2022.988502 Peer Reviewed verified by ORBi |
 | Gillot, L., Lebeau, A., Baudin, L., POTTIER, C., Louis, T., Durré, T., Longuespée, R., Mazzucchelli, G., NIZET, C., BLACHER, S., KRIDELKA, F., & Noël, A. (14 May 2022). Periostin in lymph node pre-metastatic niches governs lymphatic endothelial cell functions and metastatic colonization. Cellular and Molecular Life Sciences, 79 (6), 295. doi:10.1007/s00018-022-04262-w Peer Reviewed verified by ORBi |
 | Roblain, Q., Louis, T., Yip, C., Baudin, L., Struman, I., Caolo, V., LAMBERT, V., Lecomte, J.* , Noël, A.* , & Heymans, S.*. (2021). Intravitreal injection of anti-miRs against miR-142-3p reduces angiogenesis and microglia activation in a mouse model of laser-induced choroidal neovascularization. Aging, 13. doi:10.18632/aging.203035 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Bourgot, I.* , Primac, I.* , Louis, T., Noël, A., & Maquoi, E. (18 August 2020). Reciprocal Interplay Between Fibrillar Collagens and Collagen-Binding Integrins: Implications in Cancer Progression and Metastasis. Frontiers in Oncology, 10 (1488). doi:10.3389/fonc.2020.01488 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Primac, I., Maquoi, E., Blacher, S., Heljasvaara, R., Van Deun, J., Smeland, H. Y. H., Canale, A., Louis, T., Stuhr, L., Sounni, N. E., Cataldo, D., Pihlajaniemi, T., Pequeux, C., De Wever, O., Gullberg, D., & Noël, A. (09 July 2019). Stromal integrin alpha11 regulates PDGFR-beta signaling and promotes breast cancer progression. Journal of Clinical Investigation, 130. doi:10.1172/JCI125890 Peer Reviewed verified by ORBi |
 | Durré, T., Morfoisse, F., ERPICUM, C., Ebroin, M., Blacher, S., García Caballero, M., Deroanne, C., Louis, T., BALSAT, C., Van De Velde, M., Kaijalainen, S., Kridelka, F., Engelholm, L., Struman, I., Alitalo, K., Behrendt, N., Paupert, J., & Noël, A. (2018). uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis. Nature Communications, 9 (1), 5178. doi:10.1038/s41467-018-07514-1 Peer Reviewed verified by ORBi |
Bourgot, I., Louis, T., Hego, A., Lefevre, G., Noël, A., & Maquoi, E. (2025). Optimization of a 3D spheroid model to study the migration of cancer-associated fibroblasts in fibrillar collagen. In ALTREX Proccedings. Springer. |
